Behavioral characterization of cereblon forebrain-specific conditional null mice: A model for human non-syndromic intellectual disability-Reference-Cited by-同舟云学术

Behavioral characterization of cereblon forebrain-specific conditional null mice: A model for human non-syndromic intellectual disability

Published:2012-01 Issue:2 Volume:226 Page:428-434
ISSN:0166-4328
Container-title:Behavioural Brain Research
language:en
Short-container-title:Behavioural Brain Research

Author:

Rajadhyaksha Anjali M.,Ra Stephen,Kishinevsky Sarah,Lee Anni S.,Romanienko Peter,DuBoff Mariel,Yang Chingwen,Zupan Bojana,Byrne Maureen,Daruwalla Zeeba R.,Mark Willie,Kosofsky Barry E.,Toth Miklos,Higgins Joseph J.

Publisher

Elsevier BV

Subject

Behavioral Neuroscience

Reference56 articles.

1. A gene for nonsyndromic mental retardation maps to chromosome 3p25-pter;Higgins;Neurology,2000

2. Candidate genes for recessive non-syndromic mental retardation on chromosome 3p (MRT2A);Higgins;Clin Genet,2004

3. A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation;Higgins;Neurology,2004

4. Identification of a primary target of thalidomide teratogenicity;Ito;Science,2010

5. Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses;Miller;Teratology,1999

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational methods and key considerations for in silico design of proteolysis targeting chimera (PROTACs);International Journal of Biological Macromolecules;2024-10

2. Coordination among frequent genetic variants imparts substance use susceptibility and pathogenesis;Frontiers in Neuroscience;2024-04-10

3. The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls;EMBO Molecular Medicine;2024-03-21

4. Cereblon influences the timing of muscle differentiation in Ciona tadpoles;Proceedings of the National Academy of Sciences;2023-10-19

5. Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma;Blood Cancer Discovery;2023-09-27